Phototherapy Equipment Market Set To Grow To Over $810m By 2027

13 August 2018
Pharma

Visiongain has launched a new pharma report Global Phototherapy Equipment Market 2017-2027:Forecasts by Equipment Type (Conventional, LED-Based, Fibre-Optic), Application (Skin Disease, Neonatal Jaundice), End-User (Hospitals & Clinics, Home Use) and Geography

Phototherapy (light treatment) is the process of using light to eliminate bilirubin in the blood. These light waves are absorbed by the patient's skin and blood and change bilirubin into products which can pass through their system. Phototherapy treatment in the hospital has been traditionally been provided by a row of lights or a spotlight suspended at a distance from a baby. This would provide light shining directly on an undressed baby (with diaper on) whose eyes would need protection from the light with soft eye patches applied.

Today, advancements in technology have led to a new phototherapy system which gives effective treatment without the inconveniences of conventional phototherapy treatment. Treating psoriasis with a UVB light unit at home is an economical and convenient choice for many people. Like phototherapy in a clinic, it requires a consistent treatment schedule. Individuals are treated initially at a medical facility and then begin using a light unit at home.

The lead Visiongain report analyst for this report commented “Phototherapy is one of the most effective therapies which is carried out with the help of a special kind of light. Narrowband ultraviolet B (UVB) is the most common type of phototherapy used to treat eczema. Broadband UVB, PUVA (Psoralen and UVA) and UVA1 are other forms of phototherapy used in treating eczema.

The growth of the phototherapy market is majorly driven by rise in incidence of diseases such as neonatal jaundice, atopic dermatitis, psoriasis, vitiligo, acne vulgaris, cancer, wound healing and other skin diseases. The majority of these diseases are seen in new born children. However, the high cost of investment for research and development and high cost for relatively new classes of treatment for psoriasis and psoriatic arthritis makes the entry of new players difficult.”

The phototherapy equipment market is highly competitive with many different players entering the market. However, GE Healthcare, Philips Lighting Holding B.V. and Natus Medical Incorporated are the top competitors in the world phototherapy equipment market.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Ophthalmic Drugs market set to grow to $32bn by 2024” says Visiongain report

Successful harnessing of the opportunities for growth in the ophthalmic pharmaceuticals market will depend upon the development of novel products with technologies that increase clinical effectiveness and development of products for previously-untreated ophthalmic conditions.

15 August 2019

Read

“Global Medical Device Contract Manufacturing market set to grow to $130bn by 2024” says new Visiongain report

The available reduced costs of outsourced manufacturing combined with access to the innovation power of CMOs are major drivers behind the decision to outsource manufacturing processes.

06 August 2019

Read

“3D Printing for Healthcare market is worth $872 million in 2019” says Visiongain report

The main appeal of 3D printed healthcare products to professionals is that each unit can be personalised to fit the recipient.

02 August 2019

Read

“Global Rare Disease Drugs market set to grow to $257bn by 2024” says new Visiongain report

It is difficult to investigate rare diseases as the pool of patients is very small and often results in inadequate clinical knowledge.

01 August 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever